Skip to content

Clinical trials

Macular Degeneration trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Not applicable Clear all

241 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20043
20053
20065
200711
20086
20098
20109
201111
201211
20138
201410
201512
201615
20178
201813
201914
20205
202115
202218
202313
202412
202514
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126
Unknown status41
Recruiting31
Terminated16
Not yet recruiting12
Withdrawn11
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
VisionCare, Inc.9
Medical University of Vienna6
Duke University4
Fondation Ophtalmologique Adolphe de Rothschild4
Center for Eye Research Australia3
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts3
Hospices Civils de Lyon3
Johns Hopkins University3
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
Maastricht University Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration241
Diabetic Retinopathy27
Geographic Atrophy23
Glaucoma21
Vision Disorders14
Macular Edema11
Retinal Vein Occlusion11
Retinal Degeneration10
Vision, Low10
Choroidal Neovascularization9

Trials

Showing 51 to 75 of 241. Each trial links to its page on Pharma Observatory.

141 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.